The growth of Viagra and its effect on the drug landscape presents a complex question for investors. While the first sales data were astounding, the exclusivity has expired, leading to a deluge of off-brand alternatives that are reducing profit. In addition, the sector is facing issues related to demographic trends and evolving healthcare regula… Read More